{"id":"W4401875426","doi":"10.1016/s2152-2650(24)01697-5","title":"MM-520 Mezigdomide (MEZI) Plus Dexamethasone (DEX) and Bortezomib (BORT) or Carfilzomib (CFZ) in Patients With Relapsed/Refractory Multiple Myeloma (RRMM): Results From the CC-92480-MM-002 Trial","year":2024,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University; Université de Montréal; Hôpital Maisonneuve-Rosemont; University of Alberta","funders":"","keywords":"Carfilzomib; Medicine; Bortezomib; Dexamethasone; Multiple myeloma; Internal medicine; Oncology; Refractory (planetary science)","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001072633,0.001018726,0.00158684,0.0002619752,0.0001775471,0.0009188294,0.0006158815,0.0008006025,0.003161867],"category_scores_gemma":[0.0008658465,0.000316107,0.001247778,0.0004559795,0.0004797644,0.0006759408,0.0003674708,0.002574411,0.000726564],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007343328,"about_ca_system_score_gemma":0.0006164238,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001421091,"about_ca_topic_score_gemma":0.003628121,"domain_scores_codex":[0.9996176,0.0002045306,0.00001614518,0.00006086704,0.00003052041,0.00007045196],"domain_scores_gemma":[0.9996601,0.00006403757,0.00007877018,0.00002642127,0.00001515464,0.0001555257],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8315511,0.005596755,0.007619034,0.001314489,0.003684642,0.0001429645,0.0001266615,0.00206112,0.01196181,0.0005053339,0.008293438,0.1271427],"study_design_scores_gemma":[0.8365919,0.1105866,0.03619353,0.0001746699,0.002952616,0.0003237424,0.0001109461,0.001248146,0.001505662,0.0006302805,0.009632328,0.00004964514],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9756029,0.01636433,0.0002761727,0.001350832,0.0002721717,0.0004407254,0.001742796,0.0001226187,0.003827472],"genre_scores_gemma":[0.9850583,0.006510067,0.0005951639,0.001273551,0.0002702927,0.0004135082,0.003200928,0.00002951825,0.002648599],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003161867,"threshold_uncertainty_score":0.01057756,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04710871201371696,"score_gpt":0.3310340442538299,"score_spread":0.283925332240113,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}